BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37381703)

  • 1. Acrodermatitis continua of Hallopeau in an elderly patient successfully and rapidly treated with risankizumab: a case report.
    Orsini D; Iacovelli P; Frascione P; Pacifico A
    J Dermatolog Treat; 2023 Dec; 34(1):2229468. PubMed ID: 37381703
    [No Abstract]   [Full Text] [Related]  

  • 2. Acrodermatitis continua Hallopeau successfully treated by risankizumab.
    Hugo J; Gkalpakioti P; Arenbergerova M; Arenberger P; Gkalpakiotis S
    Int J Dermatol; 2021 Apr; 60(4):e144-e145. PubMed ID: 33368238
    [No Abstract]   [Full Text] [Related]  

  • 3. Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report.
    Battista T; Guerrasio G; De Fata Salvatores G; Peduto T; Fabbrocini G; Di Guida A
    Dermatol Ther; 2022 May; 35(5):e15383. PubMed ID: 35174591
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of acrodermatitis continua of Hallopeau evolving into generalized pustular psoriasis successfully treated with guselkumab.
    Yamamoto H; Kamiya K; Okada H; Maekawa T; Komine M; Ohtsuki M
    Int J Dermatol; 2023 Feb; 62(2):269-270. PubMed ID: 35187654
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of acrodermatitis continua of Hallopeau successfully treated with guselkumab.
    Buononato D; Licata G; Gambardella A; De Rosa A; Calabrese G; Argenziano G
    Dermatol Ther; 2022 Jul; 35(7):e15514. PubMed ID: 35420733
    [No Abstract]   [Full Text] [Related]  

  • 6. Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau.
    Wang Y; Zhang L; Zheng J; Li X; Chen L
    JAMA Dermatol; 2024 Apr; 160(4):476-477. PubMed ID: 38416455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab treatment for acrodermatitis continua of Hallopeau: three cases refractory to IL-17 inhibition.
    Zhang Z; Wu X; Han C; Chen M; Liu Y
    J Dtsch Dermatol Ges; 2023 Jul; 21(7):785-787. PubMed ID: 37186059
    [No Abstract]   [Full Text] [Related]  

  • 8. Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option?
    Megna M; Potestio L; Di Caprio N; Tajani A; Fabbrocini G; Annunziata A
    Dermatol Ther; 2022 May; 35(5):e15423. PubMed ID: 35261135
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of acrodermatitis continua of Hallopeau by TYK2 inhibitor with every other day.
    Kan Y; Uhara H
    J Dermatolog Treat; 2024 Dec; 35(1):2316239. PubMed ID: 38387442
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful therapy of acrodermatitis continua of Hallopeau with IL-23 blockers -two new cases.
    Langer N; Wilsmann-Theis D; Kromer C; Mohr J; Mössner R
    J Dtsch Dermatol Ges; 2021 Oct; 19(10):1504-1507. PubMed ID: 34581001
    [No Abstract]   [Full Text] [Related]  

  • 11. Brodalumab in the treatment of recalcitrant acrodermatitis continua of Hallopeau.
    Bardazzi F; Di Altobrando A; Lacava R
    Dermatol Ther; 2020 Nov; 33(6):e14301. PubMed ID: 32920959
    [No Abstract]   [Full Text] [Related]  

  • 12. Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
    Balestri R; Rech G; Tasin L; Rizzoli L; Girardelli CR
    J Dermatolog Treat; 2018; 29(sup1):3-5. PubMed ID: 30246571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impetigo herpetiformis; acrodermatitis continua of Hallopeau and pustular psoriasis; etiology and pathogenesis and differential diagnosis].
    GRANELLI U
    Minerva Dermatol; 1956 Apr; 31(4):120-6. PubMed ID: 13348185
    [No Abstract]   [Full Text] [Related]  

  • 14. Etanercept for pediatric acrodermatitis continua of Hallopeau: A case report and literature review.
    Ruggiero A; Patruno C; Napolitano M; Megna M; Gisonni P; Cirillo T; Fabbrocini G
    Dermatol Ther; 2020 Nov; 33(6):e14046. PubMed ID: 32700773
    [No Abstract]   [Full Text] [Related]  

  • 15. Image Gallery: Pemphigus vulgaris mimicking acrodermatitis continua of Hallopeau.
    Chen Q; Du J; Jin J; Zhang J
    Br J Dermatol; 2020 Apr; 182(4):e115. PubMed ID: 31742663
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of acrodermatitis continua of Hallopeau with adalimumab.
    Ryan C; Collins P; Kirby B; Rogers S
    Br J Dermatol; 2009 Jan; 160(1):203-5. PubMed ID: 18945314
    [No Abstract]   [Full Text] [Related]  

  • 17. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
    Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acrodermatitis continua, pustular psoriasis and impetigo herpetiformis].
    VAN SCHOUWEN M
    Ned Tijdschr Geneeskd; 1953 Jan; 97(2):79-85. PubMed ID: 13054802
    [No Abstract]   [Full Text] [Related]  

  • 19. Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report.
    Cirone KD; Lovegrove FE
    SAGE Open Med Case Rep; 2023; 11():2050313X231160937. PubMed ID: 36968989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab.
    Pavia G; Gargiulo L; Spinelli F; Avagliano J; Valenti M; Borroni RG; Costanzo A; Narcisi A
    J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e502-e505. PubMed ID: 35224780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.